Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Hims & Hers Health, Inc.HIMS · Entity 1878 | Chief Operating Officer | May 12, 2025 | May 13, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Hims & Hers Health, Inc.
Report date May 12, 2025 · Filed May 13, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 805,083 |
Ending reported balance
After 2025-05-12 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2025-05-12 · Exercise / conversion · Acquired 33,333 · Balance 838,416 F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person. Row 2 · 2025-05-12 · Sale · Disposed 13,786 · Balance 824,630 F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person. F2: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $54.405 - $55.395. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Row 3 · 2025-05-12 · Sale · Disposed 6,801 · Balance 817,829 F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person. F3: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.405 - $56.315. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Row 4 · 2025-05-12 · Sale · Disposed 7,556 · Balance 810,273 F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person. F4: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.425 - $57.32. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Row 5 · 2025-05-12 · Sale · Disposed 5,190 · Balance 805,083 F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person. F5: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $57.45 - $58.265. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.43 · Expires 2030-05-13 | Direct | 693,795 |
Reported balance
After 2025-05-12 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2025-05-12 · Exercise / conversion · Disposed 33,333 · Balance 693,795 F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person. F6: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 1,719,884 shares of Hims, Inc., with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 779,073 shares of the Company with an exercise price of $1.75. 100% of the shares subject to the option have vested. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person.
F2: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $54.405 - $55.395. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F3: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.405 - $56.315. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F4: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.425 - $57.32. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F5: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $57.45 - $58.265. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F6: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 1,719,884 shares of Hims, Inc., with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 779,073 shares of the Company with an exercise price of $1.75. 100% of the shares subject to the option have vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 03, 2024 Filed May 3, 2024 18:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 500 | $12.27 | $6,135.00 |
DisclosureSEC source: 0001773751-24-000123 · wk-form4_1714775881.xml · nonDerivative · entry 9 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 545,646 F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F6 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $12.25 - $12.30. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 03, 2024 Filed May 3, 2024 18:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 4,536 | $11.58 | $52,515.09 |
DisclosureSEC source: 0001773751-24-000123 · wk-form4_1714775881.xml · nonDerivative · entry 8 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 546,146 F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $11.21 - $12.17. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 03, 2024 Filed May 3, 2024 18:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 11,750 | $0.40 | $4,700.00 |
DisclosureSEC source: 0001773751-24-000123 · wk-form4_1714775881.xml · nonDerivative · entry 7 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 550,682 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. Read SEC document |
| May 02, 2024 Filed May 3, 2024 18:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 11,750 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-24-000123 · wk-form4_1714775881.xml · derivative · entry 13 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 716,658 Underlying: Class A Common Stock · 11,750 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F8 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| May 02, 2024 Filed May 3, 2024 18:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 6,714 | $12.08 | $81,098.41 |
DisclosureSEC source: 0001773751-24-000123 · wk-form4_1714775881.xml · nonDerivative · entry 6 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 538,932 F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $11.76 - $12.275. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 02, 2024 Filed May 3, 2024 18:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 5,036 | $12.08 | $60,824.81 |
DisclosureSEC source: 0001773751-24-000123 · wk-form4_1714775881.xml · nonDerivative · entry 5 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 545,646 F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $11.78 - $12.26. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 02, 2024 Filed May 3, 2024 18:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 11,750 | $0.40 | $4,700.00 |
DisclosureSEC source: 0001773751-24-000123 · wk-form4_1714775881.xml · nonDerivative · entry 4 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 550,682 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. Read SEC document |
| May 01, 2024 Filed May 3, 2024 18:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 11,750 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-24-000123 · wk-form4_1714775881.xml · derivative · entry 12 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 728,408 Underlying: Class A Common Stock · 11,750 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F8 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| May 01, 2024 Filed May 3, 2024 18:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 6,714 | $12.61 | $84,638.70 |
DisclosureSEC source: 0001773751-24-000123 · wk-form4_1714775881.xml · nonDerivative · entry 3 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 538,932 F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $12.23 - $13.12. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 01, 2024 Filed May 3, 2024 18:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 5,036 | $12.61 | $63,483.31 |
DisclosureSEC source: 0001773751-24-000123 · wk-form4_1714775881.xml · nonDerivative · entry 2 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 545,646 F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $12.23 - $13.12. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 01, 2024 Filed May 3, 2024 18:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 11,750 | $0.40 | $4,700.00 |
DisclosureSEC source: 0001773751-24-000123 · wk-form4_1714775881.xml · nonDerivative · entry 1 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 550,682 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. Read SEC document |
| April 08, 2024 Filed Apr 8, 2024 18:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 11,751 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-24-000100 · wk-form4_1712615913.xml · derivative · entry 12 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 740,158 Underlying: Class A Common Stock · 11,751 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F8 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| April 08, 2024 Filed Apr 8, 2024 18:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 6,715 | $14.74 | $99,005.29 |
DisclosureSEC source: 0001773751-24-000100 · wk-form4_1712615913.xml · nonDerivative · entry 9 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 538,932 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F7 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.485 - 14.955. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| April 08, 2024 Filed Apr 8, 2024 18:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 5,036 | $14.74 | $74,248.77 |
DisclosureSEC source: 0001773751-24-000100 · wk-form4_1712615913.xml · nonDerivative · entry 8 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 545,647 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F6 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.465 - 14.94. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| April 08, 2024 Filed Apr 8, 2024 18:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 11,751 | $0.40 | $4,700.40 |
DisclosureSEC source: 0001773751-24-000100 · wk-form4_1712615913.xml · nonDerivative · entry 7 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 550,683 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. Read SEC document |
| April 05, 2024 Filed Apr 8, 2024 18:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 11,751 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-24-000100 · wk-form4_1712615913.xml · derivative · entry 11 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 751,909 Underlying: Class A Common Stock · 11,751 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F8 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| April 05, 2024 Filed Apr 8, 2024 18:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 6,715 | $14.58 | $97,921.49 |
DisclosureSEC source: 0001773751-24-000100 · wk-form4_1712615913.xml · nonDerivative · entry 6 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 538,932 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.36- 14.88. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| April 05, 2024 Filed Apr 8, 2024 18:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 5,036 | $14.59 | $73,450.56 |
DisclosureSEC source: 0001773751-24-000100 · wk-form4_1712615913.xml · nonDerivative · entry 5 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 545,647 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.32 - 14.88. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| April 05, 2024 Filed Apr 8, 2024 18:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 11,751 | $0.40 | $4,700.40 |
DisclosureSEC source: 0001773751-24-000100 · wk-form4_1712615913.xml · nonDerivative · entry 4 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 550,683 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. Read SEC document |
| April 04, 2024 Filed Apr 8, 2024 18:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 11,751 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-24-000100 · wk-form4_1712615913.xml · derivative · entry 10 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 763,660 Underlying: Class A Common Stock · 11,751 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F8 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| April 04, 2024 Filed Apr 8, 2024 18:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 6,715 | $14.89 | $99,976.28 |
DisclosureSEC source: 0001773751-24-000100 · wk-form4_1712615913.xml · nonDerivative · entry 3 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 538,932 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.42 - 15.37. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| April 04, 2024 Filed Apr 8, 2024 18:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 5,036 | $14.88 | $74,956.33 |
DisclosureSEC source: 0001773751-24-000100 · wk-form4_1712615913.xml · nonDerivative · entry 2 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 545,647 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.42 - 15.33. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| April 04, 2024 Filed Apr 8, 2024 18:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 11,751 | $0.40 | $4,700.40 |
DisclosureSEC source: 0001773751-24-000100 · wk-form4_1712615913.xml · nonDerivative · entry 1 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 550,683 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 18:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 4,764 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000071 · wk-form4_1710885658.xml · derivative · entry 11 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 4,764 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2020. F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2020. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 18:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 95 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000071 · wk-form4_1710885658.xml · derivative · entry 10 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 95 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2020. F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2020. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 18:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 1,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000071 · wk-form4_1710885658.xml · derivative · entry 9 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,887 Underlying: Class A Common Stock · 1,222 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 18:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 1,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000071 · wk-form4_1710885658.xml · derivative · entry 8 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,503 Underlying: Class A Common Stock · 1,626 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 18:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 8,296 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000071 · wk-form4_1710885658.xml · derivative · entry 7 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,181 Underlying: Class A Common Stock · 8,296 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 18:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 48 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000071 · wk-form4_1710885658.xml · derivative · entry 6 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 195 Underlying: Class A Common Stock · 48 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 18:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 812 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000071 · wk-form4_1710885658.xml · derivative · entry 5 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,246 Underlying: Class A Common Stock · 812 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 18:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 18,713 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000071 · wk-form4_1710885658.xml · derivative · entry 4 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,701 Underlying: Class A Common Stock · 18,713 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F4 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022. F4 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 18:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 16,298 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000071 · wk-form4_1710885658.xml · derivative · entry 3 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 195,567 Underlying: Class A Common Stock · 16,298 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023. F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 18:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Tax withholdingClass A Common Stock | 20,407 | $14.63 | $298,554.41 |
DisclosureSEC source: 0001773751-24-000071 · wk-form4_1710885658.xml · nonDerivative · entry 2 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 538,932 F2 · shares: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 18:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 51,874 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-24-000071 · wk-form4_1710885658.xml · nonDerivative · entry 1 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 559,339 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| March 07, 2024 Filed Mar 7, 2024 20:10 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 5,036 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · derivative · entry 18 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 775,411 Underlying: Class A Common Stock · 5,036 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F8 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| March 07, 2024 Filed Mar 7, 2024 20:10 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 6,715 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · derivative · entry 17 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 780,447 Underlying: Class A Common Stock · 6,715 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F8 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| March 07, 2024 Filed Mar 7, 2024 20:10 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 5,036 | $14.35 | $72,270.13 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · nonDerivative · entry 12 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 507,465 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F7 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.08 - $14.54. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 07, 2024 Filed Mar 7, 2024 20:10 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 6,715 | $14.36 | $96,413.97 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · nonDerivative · entry 11 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 512,501 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F6 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.13- $14.66. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 07, 2024 Filed Mar 7, 2024 20:10 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 6,715 | $0.40 | $2,686.00 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · nonDerivative · entry 10 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 519,216 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. Read SEC document |
| March 07, 2024 Filed Mar 7, 2024 20:10 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 5,036 | $0.40 | $2,014.40 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · nonDerivative · entry 9 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 512,501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 20:10 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 6,715 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · derivative · entry 16 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 787,162 Underlying: Class A Common Stock · 6,715 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F8 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 20:10 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 5,036 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · derivative · entry 15 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 793,877 Underlying: Class A Common Stock · 5,036 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F8 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 20:10 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 6,715 | $13.99 | $93,915.99 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · nonDerivative · entry 8 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 507,465 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $13.72 - $14.15. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 20:10 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 5,036 | $13.99 | $70,444.07 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · nonDerivative · entry 7 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 514,180 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $13.55- $14.17. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 20:10 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 6,715 | $0.40 | $2,686.00 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · nonDerivative · entry 6 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 519,216 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 20:10 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 5,036 | $0.40 | $2,014.40 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · nonDerivative · entry 5 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 512,501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 20:10 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 5,036 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · derivative · entry 14 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 798,913 Underlying: Class A Common Stock · 5,036 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F8 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 20:10 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 6,715 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · derivative · entry 13 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 803,949 Underlying: Class A Common Stock · 6,715 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F8 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 20:10 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 5,036 | $14.22 | $71,603.36 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · nonDerivative · entry 4 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 507,465 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $13.99 - $14.475. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 20:10 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 6,715 | $14.22 | $95,459.10 |
DisclosureSEC source: 0001773751-24-000057 · wk-form4_1709860250.xml · nonDerivative · entry 3 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 512,501 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $13.96 - $14.47. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.